Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Archana S Nagaraja

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|January 26, 2013
Why stress is BAD for cancer patientsArchana S Nagaraja, Guillermo N Armaiz-Pena, Susan K Lutgendorf, et al.
Cell Metabolism|February 11, 2016
SnapShot: Stress and DiseaseArchana S Nagaraja, Nouara C Sadaoui, Piotr L Dorniak, et al.
Expert Opinion on Investigational Drugs|August 8, 2013
β-blockers: a new role in cancer chemotherapy?Archana S Nagaraja, Nouara C Sadaoui, Susan K Lutgendorf, et al.
Nature Reviews. Cancer|August 25, 2015
Sympathetic nervous system regulation of the tumour microenvironmentSteven W Cole, Archana S Nagaraja, Susan K Lutgendorf, et al.
Oncotarget|November 29, 2017
ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapyMaya Yasukawa, Yuexin Liu, Limei Hu, et al.
The Biochemical Journal|January 7, 2017
Calcium-mediated oxidative stress: a common mechanism in tight junction disruption by different types of cellular stressRuchika Gangwar, Avtar S Meena, Pradeep K Shukla, et al.
Oncotarget|June 5, 2018
ADH1B promotes mesothelial clearance and ovarian cancer infiltrationKshipra M Gharpure, Olivia D Lara, Yunfei Wen, et al.
Scientific Reports|May 1, 2021
Combined VEGFR and MAPK pathway inhibition in angiosarcomaMichael J Wagner, Yasmin A Lyons, Jean H Siedel, et al.
Cancer Biology & Therapy|May 21, 2014
Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancerNicole M Reusser, Heather J Dalton, Sunila Pradeep, et al.
Molecular Cancer Therapeutics|March 25, 2016
Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor GrowthJie Huang, Wei Hu, Limin Hu, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|January 26, 2013
Why stress is BAD for cancer patientsArchana S Nagaraja, Guillermo N Armaiz-Pena, Susan K Lutgendorf, et al.
Cell Metabolism|February 11, 2016
SnapShot: Stress and DiseaseArchana S Nagaraja, Nouara C Sadaoui, Piotr L Dorniak, et al.
Expert Opinion on Investigational Drugs|August 8, 2013
β-blockers: a new role in cancer chemotherapy?Archana S Nagaraja, Nouara C Sadaoui, Susan K Lutgendorf, et al.
Nature Reviews. Cancer|August 25, 2015
Sympathetic nervous system regulation of the tumour microenvironmentSteven W Cole, Archana S Nagaraja, Susan K Lutgendorf, et al.
Oncotarget|November 29, 2017
ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapyMaya Yasukawa, Yuexin Liu, Limei Hu, et al.
The Biochemical Journal|January 7, 2017
Calcium-mediated oxidative stress: a common mechanism in tight junction disruption by different types of cellular stressRuchika Gangwar, Avtar S Meena, Pradeep K Shukla, et al.
Oncotarget|June 5, 2018
ADH1B promotes mesothelial clearance and ovarian cancer infiltrationKshipra M Gharpure, Olivia D Lara, Yunfei Wen, et al.
Scientific Reports|May 1, 2021
Combined VEGFR and MAPK pathway inhibition in angiosarcomaMichael J Wagner, Yasmin A Lyons, Jean H Siedel, et al.
Cancer Biology & Therapy|May 21, 2014
Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancerNicole M Reusser, Heather J Dalton, Sunila Pradeep, et al.
Molecular Cancer Therapeutics|March 25, 2016
Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor GrowthJie Huang, Wei Hu, Limin Hu, et al.
Pageof 4